Search Results - "Hauser, I"

Refine Results
  1. 1

    The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients by Humar, A., Lebranchu, Y., Vincenti, F., Blumberg, E. A., Punch, J. D., Limaye, A. P., Abramowicz, D., Jardine, A. G., Voulgari, A. T., Ives, J., Hauser, I. A., Peeters, P.

    Published in American journal of transplantation (01-05-2010)
    “…Late‐onset cytomegalovirus (CMV) disease is a significant problem with a standard 3‐month prophylaxis regimen. This multicentre, double‐blind, randomized…”
    Get full text
    Journal Article
  2. 2

    A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients by Vincenti, F., Schena, F. P., Paraskevas, S., Hauser, I. A., Walker, R. G., Grinyo, J.

    Published in American journal of transplantation (01-02-2008)
    “…In a randomized, open‐label, multicenter study, de novo renal transplant patients received no steroids (n = 112), steroids to day 7 (n = 115), or standard…”
    Get full text
    Journal Article
  3. 3

    Dietary nitrate supplementation improves exercise performance and decreases blood pressure in COPD patients by Berry, Michael J., Justus, Nicholas W., Hauser, Jordan I., Case, Ashlee H., Helms, Christine C., Basu, Swati, Rogers, Zachary, Lewis, Marc T., Miller, Gary D.

    Published in Nitric oxide (01-08-2015)
    “…•Dietary nitrate consumption increases plasma nitrate and nitrite levels in chronic obstructive disease (COPD) patients.•Dietary nitrate consumption increases…”
    Get full text
    Journal Article
  4. 4

    A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection by Pliquett, R. U., Asbe-Vollkopf, A., Hauser, P. M., Presti, L. L., Hunfeld, K. P., Berger, A., Scheuermann, E. H., Jung, O., Geiger, H., Hauser, I. A.

    “…Pneumocystis jirovecii pneumonia (PCP) and cytomegalovirus (CMV) infection represent possible complications of medical immunosuppression. Between 2005 and…”
    Get full text
    Journal Article
  5. 5

    Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour by Masdea, L, Kulik, E.M, Hauser-Gerspach, I, Ramseier, A.M, Filippi, A, Waltimo, T

    Published in Archives of oral biology (01-08-2012)
    “…Abstract Objective To investigate the antimicrobial activity of the bacteriocin-producing strain Streptococcus salivarius K12 against several bacteria involved…”
    Get full text
    Journal Article
  6. 6

    IL-18 is expressed in the intercalated cell of human kidney by Gauer, S., Sichler, O., Obermüller, N., Holzmann, Y., Kiss, E., Sobkowiak, E., Pfeilschifter, J., Geiger, H., Mühl, H., Hauser, I.A.

    Published in Kidney international (01-11-2007)
    “…We determined the cellular location of interleukin-18 (IL-18) and caspase-1 and the purinergic receptor P2X7, two proteins necessary for its activation and…”
    Get full text
    Journal Article
  7. 7

    Human Pregnane X Receptor Genotype of the Donor but Not of the Recipient Is a Risk Factor for Delayed Graft Function After Renal Transplantation by Hauser, I A, Kruck, S, Gauer, S, Nies, A T, Winter, S, Bedke, J, Geiger, H, Hoefeld, H, Kleemann, J, Asbe-Vollkopf, A, Engel, J, Burk, O, Schwab, M, Schaeffeler, E

    Published in Clinical pharmacology and therapeutics (01-05-2012)
    “…Delayed graft function (DGF) is an important complication in renal transplantation, contributing significantly to decrease in long‐term allograft survival. In…”
    Get full text
    Journal Article
  8. 8

    Mechanisms of Everolimus‐Induced Glomerulosclerosis After Glomerular Injury in the Rat by Daniel, C., Renders, L., Amann, K., Schulze‐Lohoff, E., Hauser, I.A., Hugo, C.

    Published in American journal of transplantation (01-12-2005)
    “…Despite the lack of nephrotoxicity, adverse effects of the new antiproliferative immunosuppressant everolimus have been reported. By varying time point and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Can the Preprocurement Pancreas Suitability Score Predict Ischemia-Reperfusion Injury and Graft Survival After Pancreas Transplantation? by Woeste, G, Moench, C, Hauser, I.A, Geiger, H, Scheuermann, E, Bechstein, W.O

    Published in Transplantation proceedings (01-12-2010)
    “…Abstract Background Ischemia-reperfusion injury (IRI) is common after pancreas transplantation, leading to pancreatitis or thrombosis with the need for…”
    Get full text
    Journal Article Conference Proceeding
  11. 11

    Octenidine in root canal and dentine disinfection ex vivo by Tandjung, L., Waltimo, T., Hauser, I., Heide, P., Decker, E.-M., Weiger, R.

    Published in International endodontic journal (01-11-2007)
    “…Aim  The aim of the present study was to investigate the antimicrobial activity of octenidine on Enterococcus faecalis ATCC 29212 in a dentine block model…”
    Get full text
    Journal Article
  12. 12

    Adhesion of oral streptococci to all-ceramics dental restorative materials in vitro by Meier, R., Hauser-Gerspach, I., Lüthy, H., Meyer, J.

    “…In recent years, patients have benefited from the development of better and more esthetic materials, including all-ceramics dental restorative materials…”
    Get full text
    Journal Article
  13. 13

    Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion by HAUSER, I. A, RENDERS, L, RADEKE, H.-H, STERZE, R. B, GOPPELT-STRUEBE, M

    “…Mycophenolate mofetil (MMF) is used for immunosuppression after renal transplantation because it reduces lymphocyte proliferation by inhibiting inosine…”
    Get full text
    Conference Proceeding Journal Article
  14. 14

    Numerical study of conforming space‐time methods for Maxwell's equations by Hauser, Julia I. M., Zank, Marco

    “…Time‐dependent Maxwell's equations govern electromagnetics. Under certain conditions, we can rewrite these equations into a partial differential equation of…”
    Get full text
    Journal Article
  15. 15

    Incidence and Treatment of Pancreatic Fistula after Simultaneous Pancreas Kidney Transplantation by Woeste, G, Moench, C, Hauser, I.A, Geiger, H, Scheuermann, E, Bechstein, W.O

    Published in Transplantation proceedings (01-12-2010)
    “…Abstract Background Simultaneous pancreas and kidney transplantation (SPK) is associated with great postoperative morbidity, including the need for…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Risk factors for Pneumocystis jiroveci pneumonia (PcP) in renal transplant recipients by EITNER, Frank, HAUSER, IngeborgA, FISCHEREDER, Michael, RETTKOWSKI, Olaf, RATH, Thomas, LOPAU, Kai, PLIQUETT, Rainer U, FIEDLER, Roman, GUBA, Markus, HILGERS, Ralf-Dieter, FLOEGE, Jürgen

    Published in Nephrology, dialysis, transplantation (01-06-2011)
    “…Pneumocystis jiroveci pneumonia (PcP) is a potentially life-threatening complication in renal transplant recipients with increased reports during the past few…”
    Get full text
    Journal Article
  17. 17

    Remission of a B cell CLL-associated membranoproliferative glomerulonephritis Type I with rituximab and bendamustine by Bartel, C, Obermüller, N, Rummel, M J, Geiger, H, Hauser, I A

    Published in Clinical nephrology (01-04-2008)
    “…In a 56-year-old white male patient, a membranoproliferative glomerulonephritis Type I was diagnosed after a 12-month history of low grade B cell lymphoma…”
    Get more information
    Journal Article
  18. 18

    Entry‐into‐human study with the novel immunosuppressant SDZ RAD in stable renal transplant recipients by NEUMAYER, H.-H, PARADIS, K, BURKHARDT, K, LISON, A.-E, BARNDT, I, APPEL-DINGEMANSE, S, KORN, A, JEAN, C, FRITSCHE, L, BUDDE, K, WINKLER, M, KLIEM, V, PICHLMAYR, R, HAUSER, I. A

    Published in British journal of clinical pharmacology (01-11-1999)
    “…Aims To evaluate the tolerability of single oral SDZ RAD doses in stable renal transplant recipients and the pharmacokinetics of ascending SDZ RAD doses when…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    The PRIMAVERA study protocol design: Evaluating the effect of continuous erythropoiesis receptor activator (C.E.R.A.) on renal function in non-anemic patients with chronic kidney disease by Fliser, D, Dellanna, F, Koch, M, Seufert, J, Witzke, O, Hauser, I.A

    Published in Contemporary clinical trials (01-11-2011)
    “…Abstract Erythropoiesis stimulating agents (ESA) are widely used for hemoglobin correction in patients suffering from renal anemia. However, their beneficial…”
    Get full text
    Journal Article
  20. 20

    Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells by Hauser, Ingeborg A., Koziolek, Michael, Hopfer, Ulrich, Thévenod, Frank

    Published in Kidney international (01-10-1998)
    “…Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells. The immunosuppressive…”
    Get full text
    Journal Article